Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers P > Headlines for Protalix Biotherapeutics, Inc. > News item |
Protalix Biotherapeutics investor sells more than 1.1 million shares
By Lisa Kerner
Charlotte, N.C., Sept. 24 - Marathon Investments Ltd. sold 1,179,077 shares of Protalix Biotherapeutics, Inc. between Aug. 13 and Sept. 23 priced from $6.10 to $8.0147 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Thursday.
The investor beneficially owns 4,777,304 shares or 6.24% of the Carmiel, Israel, biopharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.